Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The SLC15A4-LAMTOR1 interaction licenses endolysosomal TLR-mediated mTOR signaling and inflammatory cytokine production.

bioRxiv : the preprint server for biology·2026
Same author

Author Correction: Posttranslational modifications remodel proteome-wide ligandability.

Nature chemical biology·2026
Same author

Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant Enterococcus faecium.

Nature communications·2026
Same author

Posttranslational modifications remodel proteome-wide ligandability.

Nature chemical biology·2026
Same author

Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant <i>Enterococcus faecium</i>.

bioRxiv : the preprint server for biology·2026
Same author

Pharmacological Inhibition of SLC33A1 Promotes Endoplasmic Reticulum Hyperoxidation and Induces Adaptive IRE1/XBP1s Signaling.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Nov 2, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

699

Improving Docking Power for Short Peptides Using Random Forest.

Michel F Sanner1, Leonard Dieguez2, Stefano Forli1

  • 1Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 93037, United States.

Journal of Chemical Information and Modeling
|June 14, 2021
PubMed
Summary
This summary is machine-generated.

This study introduces random forest classifiers to improve peptide docking accuracy, achieving ~70% success rates compared to traditional methods. These advancements aim to make peptide drug design as effective as small molecule drug design.

More Related Videos

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

527
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

751

Related Experiment Videos

Last Updated: Nov 2, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

699
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

527
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

751

Area of Science:

  • Computational Chemistry
  • Drug Discovery
  • Bioinformatics

Background:

  • Therapeutic peptides are increasingly important in medicine, with many approved drugs and more in clinical trials.
  • Current peptide docking methods struggle due to scoring functions optimized for small molecules.
  • This limitation hinders rational drug design for peptide-based therapeutics.

Purpose of the Study:

  • To develop improved computational methods for accurate peptide docking.
  • To enhance the success rate of peptide docking in drug design.
  • To create a high-quality dataset for training and benchmarking peptide docking models.

Main Methods:

  • Compiled the ProptPep37_2021 dataset of 322 crystallographic protein-peptide complexes.
  • Developed and trained random forest classifiers to discriminate correctly docked peptide poses.
  • Utilized a benchmark testing set of 47 protein-peptide complexes to evaluate classifier performance.

Main Results:

  • Random forest classifiers significantly improved peptide docking success rates from ~25% to an average of ~70%.
  • The developed classifiers demonstrated high accuracy on a diverse testing set.
  • The ProptPep37_2021 dataset provides valuable resources for future peptide docking research.

Conclusions:

  • The new random forest classifiers offer a substantial improvement for peptide docking accuracy.
  • These methods facilitate peptide-based drug design, bringing it closer to small molecule docking success rates.
  • The freely available dataset and classifiers will advance the field of computational peptide drug discovery.